BECN1 and neoplasm: The last strategy develops soluble Beclin 1 peptide-containing fusion proteins, where thioredoxin (Trx) confers solubility and thermal stability, pH low insertion peptide (pHLIP) triggers the fusion protein translocation across the plasma membrane in a tumor acidic environment (Ding et al., 2018).